bundle-epi-type3-example-wonderdrug
type: Bundle
node role: treeRoot
id:
  v: bundle-epi-type3-example-wonderdrug
language:
  v: en
identifier:
  system:
    v: http://ema.europa.eu/identifier
    l: identifier
  value:
    v: WONDERDRUG-500MG-BUNDLE-TYPE3
type:
  v: document
timestamp:
  v: 2023-10-27T10:00:00Z
entry:
  full url:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/Composition/composition-epi-type3-example-wonderdrug
    l: composition-epi-type3-example-wonderdrug
  resource: composition-epi-type3-example-wonderdrug
entry:
  full url:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/Organization/org-epi-type3-example-pharma
    l: org-epi-type3-example-pharma
  resource: org-epi-type3-example-pharma
entry:
  full url:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
    l: mpd-epi-type3-example-wonderdrug
  resource: mpd-epi-type3-example-wonderdrug
entry:
  resource: MedicinalProductDefinition
    id:
      v: mpd-epi-type2-example-acetaminophen-100mg
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: MedicinalProductDefinition mpd-epi-type2-example-acetaminophen-100mg identifier: http://ema.europa.eu/identifier/WONDERDRUG-100MG Names - ProductName * WonderDrug 100 mg tablets
    identifier:
      system:
        v: http://ema.europa.eu/identifier
        l: identifier
      value:
        v: WONDERDRUG-100MG
    name:
      product name:
        v: WonderDrug 100 mg tablets
entry:
  resource: MedicinalProductDefinition
    id:
      v: mpd-epi-type2-example-acetaminophen-200mg
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: MedicinalProductDefinition mpd-epi-type2-example-acetaminophen-200mg identifier: http://ema.europa.eu/identifier/WONDERDRUG-200MG Names - ProductName * WonderDrug 200 mg tablets
    identifier:
      system:
        v: http://ema.europa.eu/identifier
        l: identifier
      value:
        v: WONDERDRUG-200MG
    name:
      product name:
        v: WonderDrug 200 mg tablets
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-indication-1
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi
        l: ClinicalUseDefinition-indication-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-indication-1 Profile: ClinicalUseDefinition Indication (ePI) type: Indication subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active indication DiseaseSymptomProcedures - Concept * Fever
    type:
      v: indication
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-indication-2
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-indication-uv-epi
        l: ClinicalUseDefinition-indication-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-indication-2 Profile: ClinicalUseDefinition Indication (ePI) type: Indication subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active indication DiseaseSymptomProcedures - Concept * Pain
    type:
      v: indication
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-contraindication-1
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi
        l: ClinicalUseDefinition-contraindication-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-contraindication-1 Profile: ClinicalUseDefinition Contraindication (ePI) type: Contraindication subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active contraindication DiseaseSymptomProcedures - Concept * Severe hepatic insufficiency
    type:
      v: contraindication
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-contraindication-2
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-contraindication-uv-epi
        l: ClinicalUseDefinition-contraindication-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-contraindication-2 Profile: ClinicalUseDefinition Contraindication (ePI) type: Contraindication subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active contraindication otherTherapy Treatments - Concept * Medicinal product containing paracetamol
    type:
      v: contraindication
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-interaction-1
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi
        l: ClinicalUseDefinition-interaction-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-interaction-1 Profile: ClinicalUseDefinition Interaction (ePI) type: Interaction subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active interaction Interactants - Item[x] * Warfarin Effects - Concept * Enhanced anticoagulant effect
    type:
      v: interaction
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
    interaction:
      interactant:
        item: CodeableConcept
entry:
  resource: ClinicalUseDefinition
    id:
      v: cud-interaction-2
    meta:
      profile:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi
        l: ClinicalUseDefinition-interaction-uv-epi
    language:
      v: en
    text:
      status:
        v: generated
      div:
        v: Generated Narrative: ClinicalUseDefinition cud-interaction-2 Profile: ClinicalUseDefinition Interaction (ePI) type: Interaction subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active interaction Interactants - Item[x] * Chloramphenicol
    type:
      v: interaction
    subject:
      l: mpd-epi-type3-example-wonderdrug
      reference:
        v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
    interaction:
      interactant:
        item: CodeableConcept

composition-epi-type3-example-wonderdrug
type: Composition
id:
  v: composition-epi-type3-example-wonderdrug
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Composition composition-epi-type3-example-wonderdrug status: Final type: Package Leaflet date: 2023-10-27 author: Organization WonderPharma Inc. title: WonderDrug ePI Type 3 Example
status:
  v: final
type:
  coding: https://loinc.org/rdf/11555-4
    system:
      v: http://loinc.org
      l: loinc.org
    code:
      v: 11555-4
    display:
      v: Patient Information Leaflet
  text:
    v: Package Leaflet
subject:
  l: mpd-epi-type3-example-wonderdrug
  reference:
    v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
subject:
  l: mpd-epi-type2-example-acetaminophen-100mg
  reference:
    v: MedicinalProductDefinition/mpd-epi-type2-example-acetaminophen-100mg
subject:
  l: mpd-epi-type2-example-acetaminophen-200mg
  reference:
    v: MedicinalProductDefinition/mpd-epi-type2-example-acetaminophen-200mg
date:
  v: 2023-10-27
author:
  l: org-epi-type3-example-pharma
  reference:
    v: Organization/org-epi-type3-example-pharma
title:
  v: WonderDrug ePI Type 3 Example
section:
  title:
    v: Clinical Particulars
  code:
    coding:
      system:
        v: http://hl7.org/fhir/uv/emedicinal-product-info/CodeSystem/epi-section-codes
        l: epi-section-codes
      code:
        v: clinical-particulars
  entry:
    l: cud-indication-1
    reference:
      v: ClinicalUseDefinition/cud-indication-1
  entry:
    l: cud-indication-2
    reference:
      v: ClinicalUseDefinition/cud-indication-2
  entry:
    l: cud-contraindication-1
    reference:
      v: ClinicalUseDefinition/cud-contraindication-1
  entry:
    l: cud-contraindication-2
    reference:
      v: ClinicalUseDefinition/cud-contraindication-2
  entry:
    l: cud-interaction-1
    reference:
      v: ClinicalUseDefinition/cud-interaction-1
  entry:
    l: cud-interaction-2
    reference:
      v: ClinicalUseDefinition/cud-interaction-2
  entry:
    l: cud-undesirable-effect-1
    reference:
      v: ClinicalUseDefinition/cud-undesirable-effect-1
  entry:
    l: cud-undesirable-effect-2
    reference:
      v: ClinicalUseDefinition/cud-undesirable-effect-2
  entry:
    l: cud-warning-1
    reference:
      v: ClinicalUseDefinition/cud-warning-1
  entry:
    l: cud-warning-2
    reference:
      v: ClinicalUseDefinition/cud-warning-2
section:
  title:
    v: 1. What is in this leaflet
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi/
        l: rmswi
      code:
        v: 100000155538
    text:
      v: 1. What is in this leaflet
  text:
    status:
      v: generated
    div:
      v: 1. What is in this leaflet Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

mpd-epi-type3-example-wonderdrug
type: Uv
type: MedicinalProductDefinition
id:
  v: mpd-epi-type3-example-wonderdrug
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicinalProductDefinition mpd-epi-type3-example-wonderdrug identifier: http://ema.europa.eu/identifier/WONDERDRUG-500MG domain: Human use status: Active Contacts - Contact * Organization WonderPharma Inc. name productName: WonderDrug 500 mg tablets part part: WonderDrug type: Invented Name Part part part: 500 mg type: Strength part part part: tablets type: Form part Usages - Country Language * Estonia Estonian
identifier:
  system:
    v: http://ema.europa.eu/identifier
    l: identifier
  value:
    v: WONDERDRUG-500MG
domain:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-domain
      l: medicinal-product-domain
    code:
      v: Human
    display:
      v: Human use
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
contact:
  contact:
    l: org-epi-type3-example-pharma
    reference:
      v: Organization/org-epi-type3-example-pharma
name:
  product name:
    v: WonderDrug 500 mg tablets
  part:
    part:
      v: WonderDrug
  part:
    part:
      v: 500 mg
  part:
    part:
      v: tablets

org-epi-type3-example-pharma
type: Uv
type: Organization
id:
  v: org-epi-type3-example-pharma
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Organization org-epi-type3-example-pharma identifier: https://spor.ema.europa.eu/omswi/LOC-100000000 active: true type: Marketing authorisation holder name: WonderPharma Inc. Contacts - Address * 123 Pharma Way, 102 37 Prague 10, Czech Republic
identifier:
  system:
    v: https://spor.ema.europa.eu/omswi
    l: omswi
  value:
    v: LOC-100000000
active:
  v: true
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000034
    display:
      v: Marketing authorisation holder
name:
  v: WonderPharma Inc.
contact:
  address:
    text:
      v: 123 Pharma Way, 102 37 Prague 10, Czech Republic
    line:
      v: 123 Pharma Way
    city:
      v: Prague
    postal code:
      v: 102 37
    country:
      v: Czech Republic

ra-epi-type2-example-acetaminophen
type: RegulatedAuthorization
id:
  v: ra-epi-type2-example-acetaminophen
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: RegulatedAuthorization ra-epi-type2-example-acetaminophen identifier: http://ema.europa.eu/identifier/MA-123456789 subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active type: Marketing Authorisation region: Estonia holder: Organization WonderPharma Inc.
identifier:
  system:
    v: http://ema.europa.eu/identifier
    l: identifier
  value:
    v: MA-123456789
subject:
  l: mpd-epi-type3-example-wonderdrug
  reference:
    v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000061
    display:
      v: Marketing Authorisation
region:
  coding:
    system:
      v: http://hl7.org/fhir/country
      l: country
    code:
      v: EE
    display:
      v: Estonia
holder:
  l: org-epi-type3-example-pharma
  reference:
    v: Organization/org-epi-type3-example-pharma

ppd-epi-type2-example-acetaminophen
type: PackagedProductDefinition
id:
  v: ppd-epi-type2-example-acetaminophen
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: PackagedProductDefinition ppd-epi-type2-example-acetaminophen packageFor: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active packaging type: Box quantity: 1 packaging type: Blister containedItem Items - Reference * ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet amount: 30 Tablet
package for:
  l: mpd-epi-type3-example-wonderdrug
  reference:
    v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
packaging:
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073498
      display:
        v: Box
  quantity:
    v: 1

mid-epi-type2-example-acetaminophen
type: Uv
type: ManufacturedItemDefinition
id:
  v: mid-epi-type2-example-acetaminophen
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ManufacturedItemDefinition mid-epi-type2-example-acetaminophen status: Active manufacturedDoseForm: Tablet unitOfPresentation: Tablet Properties - Type Value[x] * colour White
status:
  v: active
manufactured dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000073664
    display:
      v: Tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet
property:
  type:
    coding:
      code:
        v: colour
  value: CodeableConcept
    coding:
      system:
        v: http://hl7.org/fhir/colour
        l: colour
      code:
        v: white
      display:
        v: White

apd-epi-type2-example-acetaminophen
type: AdministrableProductDefinition
id:
  v: apd-epi-type2-example-acetaminophen
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AdministrableProductDefinition apd-epi-type2-example-acetaminophen status: Active formOf: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active administrableDoseForm: Tablet unitOfPresentation: Tablet producedFrom: ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet RouteOfAdministrations - Code * Oral use
status:
  v: active
form of:
  l: mpd-epi-type3-example-wonderdrug
  reference:
    v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
administrable dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000073664
    display:
      v: Tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet
produced from:
  l: mid-epi-type2-example-acetaminophen
  reference:
    v: ManufacturedItemDefinition/mid-epi-type2-example-acetaminophen
route of administration:
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073619
      display:
        v: Oral use

ingredient-epi-type2-example-acetaminophen-active
type: Ingredient
id:
  v: ingredient-epi-type2-example-acetaminophen-active
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-epi-type2-example-acetaminophen-active status: Active for: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet AdministrableProductDefinition: status = active; administrableDoseForm = Tablet; unitOfPresentation = Tablet role: Active substance Codes - Concept * Paracetamol Strengths - Presentation[x] * 500 mg (Details: UCUM codemg = 'mg')/1 tablet (Details: unit-of-presentation codetablet = 'tablet')
status:
  v: active
for:
  l: mpd-epi-type3-example-wonderdrug
  reference:
    v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
for:
  l: mid-epi-type2-example-acetaminophen
  reference:
    v: ManufacturedItemDefinition/mid-epi-type2-example-acetaminophen
for:
  l: apd-epi-type2-example-acetaminophen
  reference:
    v: AdministrableProductDefinition/apd-epi-type2-example-acetaminophen
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072072
    display:
      v: Active
substance:
  strength:
    presentation: Ratio

coding: http://snomed.info/id/386661006
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 386661006
  display:
    v: Fever

coding: http://snomed.info/id/22253000
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 22253000
  display:
    v: Pain

coding: http://snomed.info/id/297950004
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 297950004
  display:
    v: Severe hepatic insufficiency

concept:
  coding: http://snomed.info/id/763158003
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 763158003
    display:
      v: Medicinal product containing paracetamol

CodeableConcept
coding: http://snomed.info/id/387342005
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 387342005
  display:
    v: Warfarin

coding: http://snomed.info/id/72054009
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 72054009
  display:
    v: Enhanced anticoagulant effect

CodeableConcept
coding: http://snomed.info/id/372551000
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 372551000
  display:
    v: Chloramphenicol

resource: ClinicalUseDefinition
  id:
    v: cud-undesirable-effect-1
  meta:
    profile:
      v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi
      l: ClinicalUseDefinition-undesirable-effect-uv-epi
  language:
    v: en
  text:
    status:
      v: generated
    div:
      v: Generated Narrative: ClinicalUseDefinition cud-undesirable-effect-1 Profile: ClinicalUseDefinition Undesirable Effect (ePI) type: Undesirable Effect subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active undesirableEffect SymptomConditionEffects - Concept * Thrombocytopenia
  type:
    v: undesirable-effect
  subject:
    l: mpd-epi-type3-example-wonderdrug
    reference:
      v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
  undesirable effect:
    symptom condition effect:
      concept:
        coding: http://snomed.info/id/29164005

http://snomed.info/id/29164005
system:
  v: http://snomed.info/sct
  l: sct
code:
  v: 29164005
display:
  v: Thrombocytopenia

resource: ClinicalUseDefinition
  id:
    v: cud-undesirable-effect-2
  meta:
    profile:
      v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirable-effect-uv-epi
      l: ClinicalUseDefinition-undesirable-effect-uv-epi
  language:
    v: en
  text:
    status:
      v: generated
    div:
      v: Generated Narrative: ClinicalUseDefinition cud-undesirable-effect-2 Profile: ClinicalUseDefinition Undesirable Effect (ePI) type: Undesirable Effect subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active undesirableEffect SymptomConditionEffects - Concept * Diarrhea
  type:
    v: undesirable-effect
  subject:
    l: mpd-epi-type3-example-wonderdrug
    reference:
      v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
  undesirable effect:
    symptom condition effect:
      concept:
        coding: http://snomed.info/id/62315008

http://snomed.info/id/62315008
system:
  v: http://snomed.info/sct
  l: sct
code:
  v: 62315008
display:
  v: Diarrhea

resource: ClinicalUseDefinition
  id:
    v: cud-warning-1
  meta:
    profile:
      v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi
      l: ClinicalUseDefinition-warning-uv-epi
  language:
    v: en
  text:
    status:
      v: generated
    div:
      v: Generated Narrative: ClinicalUseDefinition cud-warning-1 Profile: ClinicalUseDefinition Warning (ePI) type: Warning subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active Warnings - Description * Do not exceed the stated dose.
  type:
    v: warning
  subject:
    l: mpd-epi-type3-example-wonderdrug
    reference:
      v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
  warning:
    description:
      v: Do not exceed the stated dose.

resource: ClinicalUseDefinition
  id:
    v: cud-warning-2
  meta:
    profile:
      v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi
      l: ClinicalUseDefinition-warning-uv-epi
  language:
    v: en
  text:
    status:
      v: generated
    div:
      v: Generated Narrative: ClinicalUseDefinition cud-warning-2 Profile: ClinicalUseDefinition Warning (ePI) type: Warning subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/identifier#WONDERDRUG-500MG; domain = Human use; status = Active Warnings - Description * Keep out of the sight and reach of children.
  type:
    v: warning
  subject:
    l: mpd-epi-type3-example-wonderdrug
    reference:
      v: MedicinalProductDefinition/mpd-epi-type3-example-wonderdrug
  warning:
    description:
      v: Keep out of the sight and reach of children.

resource: MedicationKnowledge
  id:
    v: medication-knowledge-epi-type3-example
  meta:
    profile:
      v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicationKnowledge-uv-epi
      l: MedicationKnowledge-uv-epi
  language:
    v: en
  text:
    status:
      v: generated
    div:
      v: Generated Narrative: MedicationKnowledge medication-knowledge-epi-type3-example Profile: MedicationKnowledge (ePI) code: Paracetamol status: Active indicationGuideline dosingGuideline treatmentIntent: Fever dosage Dosages - Text * 1 tablet every 4 to 6 hours
  code:
    coding: http://snomed.info/id/387517004
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 387517004
      display:
        v: Paracetamol
  status:
    v: active
  indication guideline:
    dosing guideline:
      treatment intent:
        coding: http://snomed.info/id/386661006

http://snomed.info/id/386661006
system:
  v: http://snomed.info/sct
  l: sct
code:
  v: 386661006
display:
  v: Fever

text:
  v: 1 tablet every 4 to 6 hours

v: INV

v: Invented Name Part

v: STR

v: Strength part

v: FRM

v: Form part

v: EE

v: Estonia

v: urn:ietf:bcp:47
l: 47

v: et

v: Estonian

v: 100000073496

v: Blister

l: mid-epi-type2-example-acetaminophen
reference:
  v: ManufacturedItemDefinition/mid-epi-type2-example-acetaminophen

v: 30

v: Tablet

v: 100000000000

v: Paracetamol

v: 500

v: mg

v: mg

v: 1

v: tablet

v: tablet